Buckley Alvan D, Han Um Kevin Yo, Ganame Javier I, Salehian Omid, Karbassi Arsha
Division of Cardiology, McMaster University, Hamilton, Ontario, Canada.
JACC Adv. 2023 Jul 5;2(5):100394. doi: 10.1016/j.jacadv.2023.100394. eCollection 2023 Jul.
Coarctation of the aorta (CoA) is associated with intracranial aneurysms (IAs); however, the prevalence and risk factors (RFs) are not well described. Current practice guidelines offer inconsistent recommendations on screening for IAs in this patient population ranging from "not recommended" (European Society of Cardiology 2020) to "recommended" (American Heart Association 2018).
The purpose of this study was to determine the prevalence and RFs for IAs in patients with CoA.
We completed a systematic review and meta-analysis of studies utilizing computed tomography or magnetic resonance angiographic screening for IAs in patients with CoA.
Five cohort studies were included, representing 442 patients. The pooled prevalence of IAs in patients with CoA was 3.8% [95% CI: 0.1%-12.3%]. The results met our prespecified definition for high heterogeneity. Of 5 RFs evaluated, only hypertension was associated with the development of IAs with an odds ratio of 3.1 [95% CI: 1.1-8.2; = 0.03]. There was an observed downward trend over time in the prevalence of IAs among the studies included.
The development of IAs is likely multifactorial in etiology and there may be modifiable RFs in their development. Considering the low prevalence of IAs in the pooled result, routine screening of patients with CoA for IAs is likely of low-value.
主动脉缩窄(CoA)与颅内动脉瘤(IAs)相关;然而,其患病率和危险因素(RFs)尚未得到充分描述。目前的实践指南对于该患者群体颅内动脉瘤筛查的建议并不一致,从“不推荐”(欧洲心脏病学会,2020年)到“推荐”(美国心脏协会,2018年)。
本研究的目的是确定CoA患者颅内动脉瘤的患病率和危险因素。
我们对利用计算机断层扫描或磁共振血管造影对CoA患者进行颅内动脉瘤筛查的研究进行了系统评价和荟萃分析。
纳入了5项队列研究,共442例患者。CoA患者颅内动脉瘤的合并患病率为3.8%[95%CI:0.1%-12.3%]。结果符合我们预先设定的高异质性定义。在评估的5个危险因素中,只有高血压与颅内动脉瘤的发生相关,比值比为3.1[95%CI:1.1-8.2;P = 0.03]。在所纳入的研究中,观察到颅内动脉瘤的患病率随时间呈下降趋势。
颅内动脉瘤的发生病因可能是多因素的,其发展过程中可能存在可改变的危险因素。考虑到汇总结果中颅内动脉瘤的患病率较低,对CoA患者进行颅内动脉瘤的常规筛查可能价值不大。